Neurologist Offers Perspective on Lequembi, Alzheimer’s Drug Newly Approved by FDA
Neurology Associates' Dr. Andrea An discusses the significance of the FDA's new approval for the Alzheimer's drug Lequembi.
M-F 8 a.m. - 4 p.m. | 480 800 4890 | Insurance Info
Neurologist Offers Perspective on Lequembi, Alzheimer’s Drug Newly Approved by FDA
Long COVID Now Seen as Neurological Condition
Recent Research Shows Promise for New Parkinson’s-Symptoms Drugs
Lecanemab Has FDA Approval, But Alzheimer’s Patients Should Proceed With Caution
Alzheimer’s Drug Lecanemab Could Get FDA Accelerated Approval This Week
November: Spotlight on Alzheimer's, Epilepsy
New Discoveries for Alzheimer’s, Parkinson’s, Epilepsy: A Roundup of Some of the Latest Research
FDA Expedites Review Process of Medical Device That May Help Diagnose Parkinson’s Earlier
Rockefeller Neuroscience Institute Researchers Looking for Alzheimer’s Candidates